| dc.date.accessioned | 2020-04-28T14:19:31Z | |
| dc.date.available | 2020-04-28T14:19:31Z | |
| dc.date.issued | 2020-02-14 | |
| dc.identifier.citation | Health Protection Surveillance Centre, 'Biosafety guidance for diagnostic laboratories handling specimens from individuals with possible, probable or confirmed infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Middle East Respiratory Syndrome Coronavirus or Avian Influenza A : V3.0, 14/02/2020', [other], Health Protection Surveillance Centre, 2020-02-14 | en |
| dc.description | This guidance has been reviewed in the context of the emergence of with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the area of Wuhan, Hubei province in China. As yet, we do not fully understand the pathogenic potential and transmission dynamics of SARS-CoV-2, for further information refer to the hpsc website. | en |
| dc.language.iso | en | en |
| dc.publisher | Health Protection Surveillance Centre | en |
| dc.rights | Y | en |
| dc.subject | Covid-19 | en |
| dc.subject | Coronavirus | en |
| dc.subject | Laboratory guidance | en |
| dc.title | Biosafety guidance for diagnostic laboratories handling specimens from individuals with possible, probable or confirmed infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Middle East Respiratory Syndrome Coronavirus or Avian Influenza A : V3.0, 14/02/2020 | en |
| dc.type | other | en |
| dc.type.supercollection | edepositireland | |
| dc.contributor.corporatename | Health Protection Surveillance Centre | en |
| dc.publisher.place | ireland | en |
| dc.description.version | Version 3.0 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.relation.relatedto | TCD Covid-19 Collection | |
| dc.identifier.uri | http://hdl.handle.net/2262/92389 | |
